David Brown of the Washington Postwrites that the gel, tested on women in South Africa, reduced HIV infection risk by 39% in women who used it three
times a week.

The gel is not yet available in the United States, but the researchers are working on a version that would be safe for use in the United States.

The gel is made from a compound called tenofovir, which is already approved for use in the United States to treat HIV.